Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from JNJ

Investors Are Keeping This Healthcare Stock Long-Term

Despite an uncertain macro environment, healthcare giant Johnson & Johnson (JNJ) reported outstanding results in 2022, reflecting its business segments' continued strength. Moreover, the company has a history of increasing dividends for 60 consecutive years. Given its sustained business momentum and steady dividend payments, investors seem to stay committed to…

StockNews.com

Here's 3 Dividend Companies That Just Crossed Above Their 50 Moving Average

Trading Smarter, Not Harder With the 50-Day Moving Average Strategy

Barchart

3 Popular Large-Cap Stocks to Buy Right Now

As investors continue to digest the news of the recent bank collapses and the Federal Reserve’s quarter-percentage-point rate hike, the stock market outlook seems bumpy for some time. With speculations of an economic slowdown, investing in prominent large-cap stocks Johnson & Johnson (JNJ), Visa (V), and Merck & Co. (MRK)…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Large-Cap Pharma Stocks to Protect Your Portfolio Through 2023

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might push the economy into a recession this year. Therefore, investing in large-cap pharma stocks Johnson & Johnson (JNJ), Merck &…

StockNews.com

4 Best Pharma Stocks to Buy for the Long Haul

With the persistent rise in lifestyle diseases, the pharmaceutical industry is well poised for strong growth in the long term. Also, with the Fed likely to keep increasing the interest rates, the economy is likely to enter a recession, making pharma stocks attractive investment options. Therefore, investors could look to…

StockNews.com

The Strongest Pharma Stock This Week

Tighter bank lending and the Fed’s continued fight against inflation will likely push the economy into a recession this year. In this scenario, investors can look to invest in the pharma giant Johnson & Johnson (JNJ), given its financial strength, reliable dividend payments, and solid growth prospects. Read more….

StockNews.com

3 Large-Cap Stocks You Can Buy for Under $200

The recent financial turmoil from several bank failures, the Fed’s persistent hawkish stance to battle stubborn inflation, and renewed recession worries have kept the stock market highly volatile lately. Amid this backdrop, investors could consider buying fundamentally sound, large-cap stocks Taiwan Semiconductor (TSM), Johnson & Johnson (JNJ), and Merck (MRK),…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Want to Retire a Millionaire? 2 Stocks to Buy Now

The recent bank failures have increased the likelihood of a recession, with many economists increasing the odds of an economic slump in the next 12 months. Amid this backdrop, investors could buy fundamentally strong stocks, Johnson & Johnson (JNJ) and Pfizer (PFE), which could help retire a millionaire. Read on.

StockNews.com

3 Stocks to Buy Now That Are Worth Every Penny

Over the past year, the central bank has raised interest rates eight times to control inflation, which is still well above its 2% goal. The recent collapse of the financial system further complicates the Fed’s efforts in its fight against stubborn inflation. Amid this, it could be wise to invest…

StockNews.com

3 Highly Rated Blue-Chip Stocks for Your Portfolio

Despite a drop in inflation, recent developments have been concerning. Moreover, the Fed is in a dilemma of stabilizing the banking industry or fighting inflation. With uncertainty looming over the stock market, high-quality blue-chip stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and AbbVie (ABBV) could be solid additions to your…

StockNews.com

The Best Medical Stock That Money Can Buy

The medical industry, which thrived during the pandemic years, is envisioned to remain buoyed despite the economic headwinds, thanks to the inelastic demand the sector faces. Against this backdrop, we think the strong fundamentals of Johnson and Johnson (JNJ) make it a wise portfolio addition. Read on….

StockNews.com

3 Stocks That Could Deliver Healthy Returns This Year

The stock market will likely stay under pressure this year, with stubborn inflation and elevated interest rates. However, the Fed’s decision could largely be influenced by concerns about the recent banking crisis. Amid such uncertainty, fundamentally sound stocks Johnson & Johnson (JNJ), Abbott Laboratories (ABT), and Humana (HUM) could be…

StockNews.com

3 Hot Stocks You Don't Want to Miss out on Right Now

The Silicon Valley Bank crisis will likely deter the Fed from raising interest rates by the expected 50 basis points next week. However, since the market is expected to remain highly volatile, it could be wise to invest in fundamentally strong stocks Johnson & Johnson (JNJ), Walmart (WMT), and General…

StockNews.com

This Big Pharma Stock Is a Clear Buy in 2023

With interest rates expected to be higher than originally anticipated and fears of a looming recession weighing heavily on investors’ decisions, the stock market is expected to remain under pressure this year. Amid this backdrop, it could be wise for investors to invest in Johnson & Johnson (JNJ) due to…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

2 Stocks That'll Help You Keep Money in Your Pockets

Rising anxieties owing to the likelihood of an impending recession have weighed heavily on the stock market. Given the uncertainties are not likely to ease anytime soon, quality stocks Johnson & Johnson (JNJ) and Pfizer (PFE) might be wise portfolio additions to help you keep money in your pockets. Read…

StockNews.com

3 Powerhouse Stocks to Buy in 2023

As the Fed is expected to raise interest rates higher than expected, the revived recession fears will keep the stock market under pressure in the upcoming months. Thus, it could be wise to scoop up shares of high-quality businesses, such as Johnson & Johnson (JNJ), Humana Inc. (HUM), and AutoZone,…

StockNews.com

1 Stock to Buy for Safety in This Volatile Market

With the Fed anticipating higher interest rate hikes than previously expected, the stock market is expected to remain volatile in the upcoming months. Given its strong balance sheet, brand recognition, and solid dividend payouts, it could be safe to invest in Johnson & Johnson (JNJ). Read more….

StockNews.com

3 Extremely Safe Stocks to Pick up in 2023

Recession possibilities persist as the Fed continues to fight the stubbornly high inflation. Given the uncertainties, investors could consider adding extremely safe stocks Johnson & Johnson (JNJ), The Descartes Systems (DSGX), and Weis Markets (WMK) to their portfolios this year. Keep reading.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Hot Dividend Stocks to Buy Now and Hold Forever

Due to a barrage of strong macroeconomic data, the Federal Reserve has expressed the need to keep interest rates elevated. This is expected to keep the market volatile. Amid this backdrop, it might be wise to buy fundamentally strong dividend stocks Johnson & Johnson (JNJ), Novartis (NVS), and ARC Document…

StockNews.com

2 No-Brainer Warren Buffett Stocks to Buy in 2023

Renowned investor Warren Buffett’s value investing strategy has guided investors for decades. Buffett’s Berkshire Hathaway has significantly outperformed the broader market over the past six months. During periods of economic uncertainty, fundamentally sound Warren Buffett stocks Johnson & Johnson (JNJ) and McKesson Corp. (MCK) seem like no-brainer investments for solid…

StockNews.com

3 S&P 500 Stocks to Buy If You Like Winning

The economy proved resilient enough in 2023, as evidenced by recent strong economic reports. Following a brutal 2022, the S&P 500 has gotten a solid start this year and is expected to maintain the momentum. Hence, investors could consider buying fundamentally sound S&P 500 stocks Visa (V), Johnson & Johnson…

StockNews.com

3 Stocks to Buy Now if You Think a Bull Market Is on Its Way

The early-year market rally witnessed a reversal, with inpouring macro data, the Fed’s hawkish comments, and recessionary fears. However, on the flip side, a bull market can still materialize with economic growth remaining strong. Therefore, we think quality stocks UnitedHealth Group (UNH), Johnson & Johnson (JNJ), and Salesforce (CRM) might…

StockNews.com

3 Stocks to Help Grow Your Portfolio Over the Next Decade

As market uncertainties and risks obscure hopes and optimism, it could be wise to load up on shares of fundamentally sound companies, Johnson & Johnson (JNJ), AGCO Corp. (AGCO), and TravelCenters of America (TA), to help grow your portfolio over the next decade. Read on….

StockNews.com

The 4 Best Forever Stocks to Buy in February 2023

The stock market volatility is not expected to end anytime soon as the macroeconomic headwinds remain. So, I think fundamentally solid Johnson & Johnson (JNJ), Gilead Sciences (GILD), Stellantis (STLA), and Cardinal Health (CAH) could be the best stocks to own now and forever. Keep reading.

StockNews.com

1 Dividend Stock to Buy for Passive Income in 2023

Healthcare giant Johnson & Johnson (JNJ) has a six-decade-long history of consecutive dividend growth. So, given the uncertainties surrounding the market, this fundamentally strong dividend-paying stock might be an ideal buy now. Read more.

1 … 7 8 9 10

People

Dipanjan BanchurSince

722 stories

Sristi Suman JayaswalThe

216 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.